Clinical Trials Browser

Phase 3 × OTHER × Pyridoxine × Clear all

NCT00296036 2017-03-16

Pyridoxine and Topical Urea/Lactic Acid-Based Cream in Preventing Hand-Foot Syndrome in Patients Receiving Capecitabine for Breast Cancer or Other Cancer

Phase 3 Completed

137 enrolled 6 charts

Breast Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT00486213 2015-09-24

Pyridoxine in Preventing Hand-Foot Syndrome Caused by Capecitabine in Patients With Cancer

Phase 3 Terminated

Hand-Foot Syndrome

NCT01440621 2012-03-23

ModCRF

Phase 3 Completed

Cancer Related Fatigue

NCT00245050 2011-12-30

Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer

Phase 3 Completed

34 enrolled 9 charts

BreastGynecologic

Carcinoma, Ovarian Epithelial, Breast Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms, Breast Neoplasms, Male, Drug-Related Side Effects and Adverse Reactions